首页 | 本学科首页   官方微博 | 高级检索  
     


Cancer Site-Specific Isoforms of ENOX2 (tNOX), A Cancer-Specific Cell Surface Oxidase
Authors:Brandon Hostetler  Nicole Weston  Chinpal Kim  Dorothy M. Morré  D. James Morré
Affiliation:(1) NOX Technologies, Inc., 1291C Cumberland Avenue, West Lafayette, IN 47906, USA;(2) Department of Foods and Nutrition, Purdue University, West Lafayette, IN 47907, USA;(3) Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA
Abstract:Introduction  All neoplastic cells express one or more members of a unique family of tumor-associated cell surface ubiquinone (NADH) oxidase proteins with protein disulfide-thiol interchange activity (ENOX2 or tNOX proteins) that are characteristically blocked by quinone site inhibitors with anti-cancer activity. Methods  Analyses using two-dimensional gel electrophoresis with detection on western blots using a pan ENOX2 recombinant antibody revealed unique ENOX2 isoforms or unique combinations of isoforms of differing molecular weights and/or isoelectric points in sera of patients with cancers of different cellular or tissue origins. Results and Discussion  Isoform presence provides for broad-range cancer detection. The specific patterns and molecular weights of the isoforms present allows for identification of the cell type and/or tissue of origin of the neoplasm. ENOX2 isoform presence and relative amounts are largely independent of stage but may be proportional to tumor burden to provide indications of response to therapy and disease progression.
Keywords:Cancer site-specific isoforms  tNOX  ENOX2  ECTO-NOX  Pan ENOX2 recombinant antibody  Two-dimensional gel electrophoresis  Proteomics
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号